2016 Meeting on Genome Engineering
August 18, 2016 from 7:30 PM to 7:30 PM EDT
David Morrissey, PHD, Chief Technology Officer’s Oral Presentation is entitled, “Robust In Vivo Editing of Hepatocyte Target DNA Mediated by Lipid Nanoparticle Delivery of CRISPR/Cas9 Components”
Location
Cold Spring Harbor, NY
United States